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ABSTRACT
Objective: The aim of this study was to establish cases of bacteria associated with lower respiratory tract infections (LRTIs) in General Hospital 
Dr. Pirngadi Medan with the view to identify the bacteria well as to assess their antibiotics susceptibility.
Methods: An observation and prospective study were analyzed to patients with lower respiratory tract infection in respiratory and internal wards 
Dr. Pirngadi Hospital Medan. For the identification method of bacteria was using optochin test, catalase test, Mannitol salt agar, coagulase, indole, 
methyl red, Voges–Proskauer test, citrate, urease, and Triple Sugar Iron test.
Results: The bacteria that cause lower respiratory tract infection were Pseudomonas aeruginosa (25.53%), Klebsiella pneumoniae (17.02%), Proteus sp. 
(14.89%), Staphylococcus aureus (12.77%), Escherichia coli (10.64%), Streptococcus pneumoniae (10.64%), and Haemophilus influenzae (8.51%). The 
result of sensitivity testing showed that gentamicin is more sensitive and the resistant antibiotic is chloramphenicol among all the tested antibiotics.
Conclusion: P. aeruginosa was the most common isolated from LRTIs patients with gentamicin is the most sensitive antibiotics while chloramphenicol 
is the most resistant antibiotics among all the tested antibiotics.
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INTRODUCTION
Infection of the respiratory system is a common disease in the 
community. Respiratory infections based on the region of the infection 
are divided into upper respiratory infections and lower respiratory tract 
infections (LRTIs). In general, the cause of respiratory tract infections 
is various microorganisms, but the most are due to bacterial and viral 
infections. The mortality rate is very high in baby, children, elderly, and 
especially in countries with low- and medium-income per capita [1]. 
LRTIs are among the most common infectious diseases affecting 
humans worldwide [2]. They are important causes of morbidity and 
mortality for all age groups, and each year approximately 7 million 
people die as a direct consequence of acute and chronic respiratory 
infections [3].
The World Health Organization report in 2012 said that LRTIs, especially 
pneumonia rank fourth as the leading cause of death in the world and 
at the same time, the leading cause of death from infectious diseases 
class [4]. In research conducted in RSUP. H. Adam Malik Medan found 
that around 50% of bacterium Streptococcus viridans and Streptococcus 
pneumonia (14.6–20%) isolated from sputum, while Gram-negative 
bacteria obtained Klebsiella pneumonia, Pseudomonas, and Escherichia 
coli [5].
One of the fastest growing treatments is treated with antibiotics. This 
drug is able to cope with various types of infectious diseases caused by 
bacteria. The high use of antibiotics of more than one type and in the 
long term generally used for handling complications of severe infections 
in hospitals is one of the factors triggering the occurrence of bacterial 
resistance [6]. Bacterial resistance is one of the world’s problems. Every 
year the number of resistant bacteria always increases. The United 
States alone recorded at least 2 million people got the disease with the 
bacteria that have been resistant to some antibiotics, and about 23,000 
people died from the bacteria resistant [7]. In some Asian countries 
such as China, Taiwan, Hong Kong, the Philippines, and Singapore 
found the prevalence of bacteria such as Staphylococcus aureus which 
has been resistant to some antibiotics is high, with prevalence rates 
in China (20%), Taiwan (60%), Hong Kong (70%), The Philippines 
(5%), and Singapore (60%). Some bacteria other than S. aureus, 
such as E. coli, Klebsiella spp., Serratia spp., Citrobacter freundii, and 
Morganella spp. also show a fairly high rate of resistance [8].
Current knowledge of the organisms that cause LRTIs and their 
antibiotic susceptibility profiles are therefore necessary for the 
prescription of appropriate therapy [9]. Changes in the characteristics 
of the population as it ages and the swelling numbers of patients 
with immunocompromising conditions have increased the number 
of individuals at risk [2]. The clinical laboratory plays a key role in 
the diagnosis of these infections with lots of challenges due to the 
complexity of LRTIs including quality of specimen and diversity; 
contamination of specimens with oropharyngeal flora; a diverse 
pathogen population that includes bacteria, viruses, and fungi; and the 
complex pathophysiology of respiratory tract infections [10]. There 
are numerous organisms causing LRTI including bacteria, fungi, and 
viruses. Diagnosis of LRTIs is often missed or misdiagnosed due to the 
procedures involved. The aim of this study was to establish cases of 
bacteria associated with LRTIs in General Hospital Dr. Pirngadi Medan 




This study was conducted in General Hospital Dr. Pirngadi Medan 
between September and December 2016. The samples in this study 
were those that met the inclusion and exclusion criteria. The inclusion 
criteria of the study are the patient with a clinical diagnosis is a lower 
respiratory tract infection, adult patients (over 18 years), and patients 
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with LRTIs undergoing treatment with antibiotics of one type or more 
of one type of antibiotic. The exclusion criteria are the patients who 
are not willing to participate in the study. Recent study resulted that 
only 47 patients included as inclusion criteria from 100 patients 
respondent.
Sample collection
Early morning sputum specimens were aseptically collected into 
appropriate sterile containers from 47 patients who are willing for 
taking their sputum. Each container was clearly labeled with sex and 
age of the patient and transported to the laboratory.
Microbiological analysis
The samples were cultured on blood agar and MacConkey agar plates. 
The plates were then incubated at 37°C for 24 h. Gram staining was 
carried out to differentiate the bacteria into Gram positive and Gram 
negative [11].
Identification
Organisms isolated were identified through various biochemical tests. 
These include optochin test, catalase test, Mannitol salt agar, coagulase, 
indole, methyl-red, Voges–Proskauer test, citrate, urease, and Triple 
Sugar Iron test.
Antibiotic susceptibility testing
Test of bacterial susceptibility to antibiotics was done by disc diffusion 
method. This method is performed using a filter paper disc containing 
a certain amount of antibiotics placed on the surface of a solid medium 
(blood agar) that has been inoculated with bacteria. Then, it is incubated 
at 37°C for 18–24 h. Futher observations were made by observing the 
inhibition zone. Clear areas/zones indicate the absence of bacterial 
growth. Measurements are made using the sliding or antibiotic zone 
reader. The result of bacterial sensitive or resistant to antibiotics will ke 
known by comparing the diameters of clear areas(inhibition zone) with 
standar tables performed by Clinical Laboratory Standards Institute 
(CLSI). The following Table 1 showed the inhibitory zone of antibiotics 
according to CLSI [12-14].
RESULTS AND DISCUSSION
From the screening results, from 47 patients, the majority of causes of 
LRTIs are Gram-negative bacteria. Distribution of bacteria in patients with 
LRTIs is 36 Gram-negative bacteria and 11 Gram-positive bacteria. Bacteria 
that cause LRTIs are shown in Table 2. The most common bacteria found as 
a cause of LRTIs is Pseudomonas aeruginosa. Overall, the largest percentage 
of bacteria that cause LRTIs were P. aeruginosa 25.53%, Klebsiella 
pneumoniae 17.02%, Proteus sp. 14.89%, S. aureus 12.77%, E. coli 10.64%, 
Streptococcus pneumoniae 10.64%, and Haemophilus influenzae 8.51%.
Table 1: Inhibitory zones for some antibiotics [15]
Antibiotics Antibiotics amount (µg) Diameter zona (mm)
Resistant Intermediate Sensitif
Ceftriaxone 30 0–13 14–20 ≥21
Amoxicillin 20/10 0–13 14–17 ≥18
Ampicillin 10 0–13 14–16 ≥17
Cefotaxime 30 0–14 15–22 ≥23
Cotrimoxazole 1.25/23.7 0–10 11–15 ≥16
Tetracycline 30 0–14 15–18 ≥19
Ceftazidime 30 0–14 15–17 ≥18
Meropenem 10 0–13 14–15 ≥16
Amikacin 30 0–14 15–16 ≥17
Gentamicin 10 0–6 7–8 ≥9
Ciprofloxacin 5 0–15 16–20 ≥21
Aztreonam 30 0–15 16–21 ≥22
Table 2: Percentage of bacterial cause for LRTIs
Bacteria Count (%)
Pseudomonas aeruginosa 12 (25.53)
Klebsiella pneumoniae 8 (17.02)
Proteus sp. 7 (14.89)
Staphylococcus aureus 6 (12.77)
Escherichia coli 5 (10.64)
Streptococcus pneumonia 5 (10.64)
Haemophilus influenza 4 (8.51)
Total 47 (100.00)
LRTIs: Lower respiratory tract infections
Fig. 1: Sensitivity of bacteria that cause lower respiratory tract infections against antibiotics
186
Asian J Pharm Clin Res, Vol 11, Issue 9, 2018, 184-187
 Naldi et al. 
According to Setyati and Murni in General Hospital Dr. Sardjito 
Yogyakarta found bacteria that cause pneumonia which is Gram-
positive group as much as 39.3% and Gram negative as much as 60.6%. 
P. aeruginosa was the most common bacteria (39.3%), followed by 
K. pneumoniae (19.1%). While comparing to Kumala research at the 
Clinical Microbiology Laboratory of Faculty of Medicine University of 
Indonesia in 2010, the most common cause of LRTIs are Gram-negative 
bacteria (95%) consisting of K. pneumoniae (23%) and P. aeruginosa 
(11%), while Gram-positive bacteria are only 5%. This proves that the 
bacteria that cause LRTIs in this study are similar [16,17].
Table 3 and Fig. 1 showed that the percentage of susceptibility values of 
bacterial LRTIs against antibiotics. In the table, it is seen that gentamycin 
is the most sensitive antibiotic to bacteria that LRTIs. Gentamicin was 
more sensitive (78.72%) than with other antibiotics such as amikacin 
(76.60%), meropenem (74.47%), cefotaxime (65.96%). Antibiotics that 
started to be resistant to bacteria that cause LRTIs are chloramphenicol 
(36.17%) and followed by ampicillin (23.40%).
From the results of the sensitivity test of bacteria that cause LRTIs against 
some antibiotics (Table 3), S. aureus bacteria have good sensitivity to 
cefotaxime (100%) and meropenem (100%), but S. aureus bacteria 
begin to resist the amikacin (16.67%) and chloramphenicol (33.33%). 
The bacteria K. pneumoniae have good sensitivity to gentamicin (100%), 
meropenem (87.5%), and amikacin (87.5%), but these bacteria were 
resistant to ampicillin (0%) and chloramphenicol (25%) antibiotics. 
P. aeruginosa bacteria were sensitive to amikacin (91.67%), gentamicin 
(66.67%), and meropenem (66.67%), and P. aeruginosa was resistant to 
ampicillin (16.67%) and chloramphenicol (41.67%).
Then, for H. influenzae bacteria had good sensitivity to amikacin 
(100%), cefotaxime (75%), gentamicin (75%) but already resistant to 
ampicillin antibiotics (33.33%) and chloramphenicol (0%). Proteus sp. 
was sensitive to gentamicin (100%), amikacin (71.43%), meropenem 
(71.43%), and cefotaxime (57.14%) and resistant to chloramphenicol 
(42.86%) and ampicillin (0%). S. pneumonia bacteria have sensitivity 
to cefotaxime (100%), amikacin (60%), chloramphenicol (60%), 
gentamicin (60%), meropenem (60%), and begin to resist ampicillin 
(40%). E. coli bacteria had the highest sensitivity to amikacin (100%), 
gentamicin (100%), meropenem (80%), and cefotaxime (60%). 
E. coli was resistant to ampicillin (20%) and chloramphenicol (40%). 
Factors that facilitate the development of resistance in hospitals are 
the continuous use of antibiotics, the use of irrational antibiotics, 
long-term use of antibiotics, poor sexual, and sanitary (hygiene) 
behaviors [18].
CONCLUSION
Based on the results of identification of bacteria causing LRTIs were 
P. aeruginosa 12 samples (25.53%), K. pneumoniae 8 samples (17.02%), 
Proteus sp. 7 samples (14.89%), S. aureus 6 samples (12.77%), 
E. coli 5 samples (10.64%), S. pneumoniae 5 samples (10.64%), and 
H. influenzae 4 samples (8.51%). Antibiotics with the highest sensitivity 
to bacteria that cause LRTIs were gentamicin (78.72%), followed by 
amikacin (76.60%), meropenem (74.47%), and cefotaxime (65.96%). 
Antibiotics that have low sensitivity to bacteria that cause LRTIs are 
ampicillin (23.40%) and chloramphenicol (36.17%).
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